To be presented in Brussels on 6 May, the analyses combine data from Europol’s operational intelligence on organised crime with the EMCDDA’s drug monitoring system.
These are the first in a series of online modules exploring the EU drug market. Further modules will be published in 2023 to complete the strategic analysis. These will cover amphetamine, cannabis, heroin, MDMA and new psychoactive substances, as well as impacts, drivers and responses.
A press release, with the main highlights on cocaine and methamphetamine, will be available on 6 May.
Press conference
Date: 6 May 2022
Time: 10.30 Central European Time (CEST/Brussels), 09.30 (WEST/Lisbon).
Venue: Résidence Palace, 155 Rue de la Loi, B-1040 Brussels (Polak room).
Registration: press@europol.europa.eu or press@emcdda.europa.eu
Press contacts
Europol press office: press@europol.europa.eu — Tel. (31) 703 02 50 01
EMCDDA press office: press@emcdda.europa.eu — Tel. (351) 211 21 02 00 | (351) 935 994 027
The EMCDDA–Europol EU drug markets analysis is released every three years. The last report was published in 2019.
New Europol and EMCDDA Analyses of the European Drug Market
